IDRA - Idera Pharmaceuticals reports Q3 results
Idera Pharmaceuticals (NASDAQ:IDRA): Q3 GAAP EPS of -$0.11. Press Release Cash position as of September 30, 2021 was $36.6 million.
For further details see:
Idera Pharmaceuticals reports Q3 resultsLink your Twitter Account to Market Wire News
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Stock Information
Get IDRA Alerts
News, Short Squeeze, Breakout and More Instantly...